Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrzej Pilc

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Idrugs : the Investigational Drugs Journal|June 6, 2003
LY-354740 (Eli Lilly)Andrzej Pilc
Archivum Immunologiae Et Therapiae Experimentalis|December 2, 2008
The use of citation indicators to identify and support high-quality research in PolandAndrzej Pilc
Pharmacology & Therapeutics|June 22, 2007
Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugsAgnieszka Palucha, Andrzej Pilc
Archives of Medical Science : AMS|October 4, 2016
An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitisPaweł Kawalec, Andrzej Pilc
Polish Journal of Pharmacology|July 18, 2003
On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressantsAgnieszka Pałucha, Andrzej Pilc
Drugs of Today (Barcelona, Spain : 1998)|January 6, 2006
GABAergic hypotheses of anxiety and depression: focus on GABA-B receptorsAndrzej Pilc, Gabriel Nowak
Expert Opinion on Investigational Drugs|May 31, 2013
Glutamate-based anxiolytic ligands in clinical trialsJoanna M Wierońska, Andrzej Pilc
Behavioural Brain Research|October 23, 2012
A selective mGlu7 receptor antagonist MMPIP reversed antidepressant-like effects of AMN082 in ratsAgnieszka Pałucha-Poniewiera, Andrzej Pilc
Pharmacology & Therapeutics|August 28, 2018
Depression and schizophrenia viewed from the perspective of amino acidergic neurotransmission: Antipodes of psychiatric disordersJoanna M Wierońska, Andrzej Pilc
Neurochemistry International|May 12, 2009
Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugsJoanna M Wierońska, Andrzej Pilc
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Idrugs : the Investigational Drugs Journal|June 6, 2003
LY-354740 (Eli Lilly)Andrzej Pilc
Archivum Immunologiae Et Therapiae Experimentalis|December 2, 2008
The use of citation indicators to identify and support high-quality research in PolandAndrzej Pilc
Pharmacology & Therapeutics|June 22, 2007
Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugsAgnieszka Palucha, Andrzej Pilc
Archives of Medical Science : AMS|October 4, 2016
An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitisPaweł Kawalec, Andrzej Pilc
Polish Journal of Pharmacology|July 18, 2003
On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressantsAgnieszka Pałucha, Andrzej Pilc
Drugs of Today (Barcelona, Spain : 1998)|January 6, 2006
GABAergic hypotheses of anxiety and depression: focus on GABA-B receptorsAndrzej Pilc, Gabriel Nowak
Expert Opinion on Investigational Drugs|May 31, 2013
Glutamate-based anxiolytic ligands in clinical trialsJoanna M Wierońska, Andrzej Pilc
Behavioural Brain Research|October 23, 2012
A selective mGlu7 receptor antagonist MMPIP reversed antidepressant-like effects of AMN082 in ratsAgnieszka Pałucha-Poniewiera, Andrzej Pilc
Pharmacology & Therapeutics|August 28, 2018
Depression and schizophrenia viewed from the perspective of amino acidergic neurotransmission: Antipodes of psychiatric disordersJoanna M Wierońska, Andrzej Pilc
Neurochemistry International|May 12, 2009
Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugsJoanna M Wierońska, Andrzej Pilc
Pageof 16